✦ LIBER ✦

A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)

✍ Scribed by L. Burt Nabors; Thomas Mikkelsen; Monika E. Hegi; Xiaubu Ye; Tracy Batchelor; Glenn Lesser; David Peereboom; Myrna R. Rosenfeld; Jeff Olsen; Steve Brem; Joy D. Fisher; Stuart A. Grossman; for the New Approaches to Brain Tumor Therapy (NABTT) Central Nervous System Consortium

Book ID: 112067188
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 854 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27585

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase 2b, Double-Blind, Randomized Stu

A Phase 2b, Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared With Placebo (PBO) When Administered in Combination With Chemotherapy (Modified FOLFOX6) for First-line Treatment (tx) of Patients (Pts) With Metastatic Colorectal Cancer (mCRC). The RESPECT Trial

✍ J. Tabernero; R. Garcia-Carbonero; C.H. Könne; P.J. O'Dwyer; A. Sobrero; E. Van 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB